Gender specificity of a genetic variant of angiotensin-converting enzyme and risk of coronary artery disease

被引:0
|
作者
Negar Firouzabadi
Nader Tajik
Ehsan Bahramali
Hooman Bakhshandeh
Mohsen Maadani
Massoumeh Shafiei
机构
[1] School of Medicine,Department of Pharmacology
[2] Tehran University of Medical Sciences,Division of Transplant Immunology and Immunogenetics, Department of Immunology
[3] School of Medicine,Department of Cardiology and Cardiovascular Research
[4] Tehran University of Medical Sciences,Department of Epidemiology and Biostatistics
[5] Rajaee Heart Center,undefined
[6] Tehran University of Medical Sciences,undefined
[7] Rajaee Heart Center,undefined
[8] Tehran University of Medical Sciences,undefined
来源
Molecular Biology Reports | 2013年 / 40卷
关键词
Renin-angiotensin system; Angiotensin-converting enzyme; Coronary artery disease; Genetic polymorphism; Single nucleotide polymorphism;
D O I
暂无
中图分类号
学科分类号
摘要
Etiological factors for coronary artery disease (CAD) involve a wide range of gene and environmental interactions. One of the systems being implicated in the pathophysiology of CAD is the renin-angiotensin system (RAS). However, the genetic polymorphisms of this system have not been widely studied in Iranian patients diagnosed with CAD. The aim of this study was to assess the relationship between six gene polymorphisms of RAS components and CAD in a sample of Iranian population. A total of 374 participants were enrolled in a case/control study. The presence of CAD was determined by coronary angiography. Genotyping of six RAS gene polymorphisms was performed using a modified PCR–RFLP method. Our results revealed, for the first time, a significant independent association of angiotensin-converting enzyme (ACE) A-240T polymorphism and incidence of CAD among Iranian women (P = 0.005, OR = 20.4, 95 % CI = 2.49–41.2). There has also been a significant difference in genotype distribution of ACE A-240T (P = 0.008) and angiotensin II receptor type 2 C3123A polymorphism (P = 0.032) in Iranian female participants. In conclusion, TT genotype of ACE A-240T seems to be a genetic risk factor for CAD in Iranian women.
引用
收藏
页码:4959 / 4965
页数:6
相关论文
共 50 条
  • [21] Angiotensin-converting enzyme gene D-allele and the severity of coronary artery disease
    Vladeanu, Maria-Cristina
    Bojan, Iris Bararu
    Bojan, Andrei
    Iliescu, Dan
    Badescu, Minerva Codruta
    Badulescu, Oana Viola
    Badescu, Magda
    Georgescu, Catalina Arsenescu
    Ciocoiu, Manuela
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (04) : 3407 - 3411
  • [22] Clinical Value of Angiotensin-converting Enzyme Inhibitor and Angiotensin Receptor Blocker in the Patients of Coronary Artery Disease
    Abe, Daisuke
    Sato, Akira
    Misaki, Masako
    Takeyasu, Noriyuki
    Hoshi, Tomoya
    Aonuma, Kazutaka
    CIRCULATION, 2013, 128 (22)
  • [23] Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
    Brugts, Jasper Jan
    Isaacs, Aaron
    Boersma, Eric
    van Duijn, Cock M.
    Uitterlinden, Andre G.
    Remme, Willem
    Bertrand, Michel
    Ninomiya, Toshiharu
    Ceconi, Claudio
    Chalmers, John
    MacMahon, Stephen
    Fox, Kim
    Ferrari, Roberto
    Witteman, Jacqueline C. M.
    Danser, A. H. Jan
    Simoons, Maarten L.
    de Maat, Moniek P. M.
    EUROPEAN HEART JOURNAL, 2010, 31 (15) : 1854 - 1864
  • [24] Angiotensin-I-converting enzyme DD genotype is a risk factor of coronary artery disease
    Sigusch, HH
    Vogt, S
    Gruber, U
    Reinhardt, D
    Lang, K
    Surber, R
    Farker, K
    Muller, S
    Hoffmann, A
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1997, 57 (02) : 127 - 132
  • [25] Coronary artery disease and endothelial nitric oxide synthase and angiotensin-converting enzyme gene polymorphisms
    Nakagami, H
    Ikeda, U
    Maeda, Y
    Yamamoto, K
    Hojo, Y
    Kario, K
    Kuroki, S
    Shimada, K
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1999, 8 (03) : 191 - 195
  • [26] Current perspective on the use of angiotensin-converting enzyme inhibitors in the management of coronary (atherosclerotic) artery disease
    Cheng, JWM
    Ngo, MN
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (12) : 1499 - 1506
  • [27] Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease
    Alvarez, R
    Reguero, JR
    Batalla, A
    Iglesias-Cubero, G
    Cortina, A
    Alvarez, V
    Coto, E
    CARDIOVASCULAR RESEARCH, 1998, 40 (02) : 375 - 379
  • [28] Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease
    Wang, XL
    McCredie, RM
    Wilcken, DEL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) : 115 - 119
  • [29] Coronary Artery Disease and Endothelial Nitric Oxide Synthase and Angiotensin-Converting Enzyme Gene Polymorphisms
    Hironori Nakagami
    Uichi Ikeda
    Yoshikazu Maeda
    Keiji Yamamoto
    Yukihiro Hojo
    Kazuomi Kario
    Shigehiro Kuroki
    Kazuyuki Shimada
    Journal of Thrombosis and Thrombolysis, 1999, 8 : 191 - 195
  • [30] Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
    Meurs, Kathryn M.
    Stern, Joshua A.
    Atkins, Clarke E.
    Adin, Darcy
    Aona, Brent
    Condit, Julia
    DeFrancesco, Teresa
    Reina-Doreste, Yamir
    Keene, Bruce W.
    Tou, Sandy
    Ward, Jessica
    Woodruff, Kathleen
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2017, 18 (04) : 1 - 4